If the deal happens, this will still be the largest overseas acquisition by Indian pharma industry, marginally topping Lupin's buyout of US-based Gavis Pharma for $880 million two years ago. Intas acquired Teva's Actavis units in the UK and Ireland for $732 million last August. India's $36-billion pharma ...
Read more: Intas low-balls Mallinckrodt unit bid to $1 billion on legal fears